text: Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension Chronic thromboembolic pulmonary hypertension is an underdiagnosed and potentially fatal subgroup of pulmonary hypertension if left untreated Clinical signs include exertional dyspnea and non specific symptoms Diagnosis requires multimodality imaging and heart catheterization Pulmonary endarterectomy an open heart surgery is the gold standard treatment of choice in selected patients in specialized centers Targeted medical therapy and balloon pulmonary angioplasty can be effective in high risk patients with significant comorbidities distal pulmonary vascular obstructions or recurrent persistent pulmonary hypertension after pulmonary endarterectomy Currently there is a limited number of data regarding novel coronavirus 2019 infection in patients with chronic thromboembolic pulmonary hypertension and the changing spectrum of the disease during the pandemic Challenging times during this outbreak due to healthcare crisis and relatively higher case fatality rates require convergence that is an ultradisciplinary collaboration which crosses disciplinary and sectorial boundaries to develop integrated knowledge and new paradigms Management strategies for the new normal such as virtual care preparedness for further threats redesigned standards and working conditions reevaluation of specific recommendations and online collaborations for optimal decisions for chronic thromboembolic pulmonary hypertension patients may change the poor outcomes 